Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amerchol is a leading supplier of specialty ingredients and performance chemicals for the personal care and pharmaceutical industries. Originally an independent corporation, it is now a subsidiary of Dow. The company specializes in lanolin-based derivatives, methyl glucoside derivatives, and high-performance polymers such as Polyquaternium-10. Its products are widely used as emollients, humectants, and conditioning agents in topical formulations and hair care products. Amerchol's expertise lies in providing functional excipients that improve the texture, stability, and delivery of active ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amerchol.